LipimetiX Development
2012
FOUNDED
PRIVATE
STATUS
Corporate
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Developer of drugs for cholesterol related diseases. The company focuses on the development of drugs for the treatment of refractory hypercholesterolemia and hypertriglyceridemia. Its technology is based upon a platform of chimeric peptide mimetics of apolipoprotein E, a critical protein that directs cholesterol and triglyceride rich lipoproteins to receptors on the liver. It also provides drugs for acute pancreatitis, coronary artery and peripheral artery diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
- 5 Commonwealth Road
- Suite 2A
- Natick, MA 01760
- United States
+1 (508) 000-0000
LipimetiX Development Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore LipimetiX Development‘s full profile, request access.
Request full access to PitchBookLipimetiX Development Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore LipimetiX Development‘s full profile, request access.
Request full access to PitchBook